<SEC-DOCUMENT>0001493152-26-034197.txt : 20260722
<SEC-HEADER>0001493152-26-034197.hdr.sgml : 20260722
<ACCEPTANCE-DATETIME>20260722100013
ACCESSION NUMBER:		0001493152-26-034197
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260722
FILED AS OF DATE:		20260722
DATE AS OF CHANGE:		20260722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OKYO Pharma Ltd
		CENTRAL INDEX KEY:			0001849296
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41386
		FILM NUMBER:		261192232

	BUSINESS ADDRESS:	
		STREET 1:		55 PARK LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 1NA
		BUSINESS PHONE:		44 (0) 207 495 2379

	MAIL ADDRESS:	
		STREET 1:		55 PARK LANE
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 1NA
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>July
2026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number:</B> 001-41386</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>OKYO
Pharma LTD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in Its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>9<SUP>th
</SUP>Floor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>107
Cheapside</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>London
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>EC2V
6DN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of registrant&rsquo;s principal executive office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746; Form 40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 22, 2026, OKYO Pharma LTD (the &ldquo;<U>Company</U>&rdquo;) issued this 6K announcing Gary S. Jacob, PhD, Chief Development Officer
and Director of OKYO Pharma has increased his holdings with the purchase of 3,500 of the Company&rsquo;s ordinary shares on NASDAQ at
$1.40 per share, bringing his total holding to 112,420 ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Announcement is furnished herewith as Exhibit 99.1 to this Report on Form&nbsp;6-K. The information in the attached Exhibits 99.1 is
being furnished and shall not be deemed &ldquo;filed&rdquo; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934,
or otherwise subject to the liabilities of that Section, This report on Form 6-K is hereby incorporated by reference into the Company&rsquo;s
Registration Statement on Form F-3 (Reg. No. 333-293145)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OKYO
    Pharma LTD</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    &nbsp;July 22, 2026</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Keeren Shah</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Keeren
    Shah</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">News Announcement, dated July 22, 2026</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OKYO
Pharma Announces Purchase of Shares by Chief Development Officer and Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">London
and New York, NY, July 22, 2026. OKYO Pharma Limited (Nasdaq: <U>OKYO</U>), a clinical-stage biopharmaceutical company developing investigational
therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced that Gary S. Jacob,
PhD, Chief Development Officer and Director of OKYO Pharma has increased his holdings with the purchase of 3,500 of the Company&rsquo;s
ordinary shares on NASDAQ at $1.40 per share, bringing his total holding to 112,420 ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
OKYO Pharma</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OKYO
Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic
corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed for trading on the Nasdaq Capital Market. OKYO plans
to initiate a global Phase 3 pivotal clinical trial in the second half of this year, enrolling approximately 111 patients to evaluate
a single-dose regimen of urcosimod for the treatment of NCP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further information, please visit&nbsp;<U>www.okyopharma.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
further inquiries:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OKYO
Pharma Ltd</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
Spencer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Development and Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+44
(0) 207 495 2379</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>info@okyopharma.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  1@# 2(  A$! Q$!_\0
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M,K4\/A,%@J%7%8O$UZLE"G1P^&H4ZM>O4E)I*%*G*5KM\J3E'V:4XW<,<$'
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MZB$,.L^#/'GQ,\.:GI[ET87-DMMXOETS[0I& +[3+R"12R2Q,K#'YC_M!_\
M!LS\--5MK[5/V7_CYXG\%:HJ"2T\'_&.RM?&7AB:4-,9(?\ A+?#=AH_B72(
M&0P)&\VC>*)X_*=V:9I<1I8+&4/>I23>_+%\MVNZDK/MU.G_ (F+^C_XA1EE
M7&G#V(PM&NG2]OQ/PUEV88>'M+)5'F63SQ^.RMJS7MZ:HQCRQJ>\Z;O^HW_!
M/O\ X*S?LW_M\V?_  C'A][GX5_':QTY[[6?@IXSU&UN-2N[:WCD:[U3X>>)
M(8+6P^(.B6VQVN3:66E^)M-AC>ZUSPKI=B]G=7GZLU_F<_M(_L+?MJ?\$_\
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M,YX^'F.G&,JO$^-]I*,93M'%27-)*3M*>9.3U>[MY16Q_CM?\-N?\%#M$/\
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M!'[8WPU_96\<?\%6/^"E?[4G[;&G?LG_  IT#3/%WPG_ &:1^TY\;?#?C_\
M:O\ $>JZKIFC?#K3/$=W+XN>Z\!?"'QMXNU?0=#M)Y('U[Q?IU[J/B 66D^"
M;:RU/Q?]J_\ !$;_ (-S(_#[>#?VOO\ @HCX)M[OQ$/L7BCX1?LH^*+>"\L?
M#\F5N-'\:?'O2I4GL]0\0NJ0:MHOPJO!<V6@DV4_C^"3Q+#=^%-!^W?^#LC6
MM0TG_@F5X'TFRNKBUMO$_P"UE\+-+UJ&WD:*'4=.T_P+\5M?@L+R)'"36D6L
M:1I6I1PRB5$N],LY0/-@B=?J<3G/#\<SRC@/A7"X.."JXNGE^99VL/@\3B7%
MQKRQT<!C:F&K5*^+KTJ,Z-7,IU:M"E.I+ZE34J=/$TO"HY9F[P68\6Y_6K2K
MTL/6Q>#REU*U*G!I4UAOK-*-?DAAJ3J1J4L)[+]ZDG7G[\H2_D8_:6_X+S_\
M%0_VD?%&H:V?VFO&?[/_ (2,L\6@_#?]FO4;SX2^&?#&E^9(]MIZ>(-!N8/'
MOB"6R@,,$NJ>(O%5_<3E%\B+3[1UMH?C\?MK?\%#=1S?)^US^VUJ(NCYS7I^
M/'QXG6X9\N94FC\6R)('W;MZN0P*D5^A7_!N3\"_A9\??^"IWPN\/_%WP7H'
MQ \,^"?A[\4OBCI_ACQ3IUKK'A^Z\6^%=-T^Q\,7^JZ/?136.JIH5[KAUO3[
M6^AN+:'6=/TO4/*\[3X"/]1&SM[>VA6VMK>"VMX%6*"WMX8X((8T!"I%%&JI
M&@YPJJ%'0 #BO5XHXKR+@C,*628+A++L3RX6GB)R=/ X>E"$ZN(I4J47/+,;
MBJLDL.YNI/%)OF]^567/*?GY%P_FO%.%J9IBN(<90Y\16HJFG7J/F@X.4DEB
MZ-.G!N5H0IQCRQC%?"DC_'E'[9/_  4/YS^U9^VP>/\ HN?Q\X/K_P C55[3
M/^"A7_!1KP'?P75A^VO^V=X:O)CNA6\_:%^-%JEVT)#E7L=5\526NHPQL4+P
M36MS PXDC960/_L+X'H/R%?'?[>O[-/PE_:J_9,^/GPF^+/A#P[XDTK7OA/X
M_31M3U;0].U;5/!GB:'PIJTGAWQKX6N;V%YM)\3>%M66UUG1M0LYK>>*[M$1
MI#!)-&_S]#Q5RNM7I4<1P9EE/#U:M*G4E#ZA6E!3J0IN?LZV3J%6,%4YG3DX
MJ2BXWU1Z]7P_S"C2JUJ/$^-=2E2J5*<6L7%2E3A.HHMPS/W>9P4>9)VO=IZG
M\;__  1@_P"#BO\ :6F_:'^%7[+'[<_C&+XS_#7XR>*=!^&_@KXRZQ9:+HGQ
M(^&?CKQ-J:Z7X0_X2W6M)M-)TOQMX&\0:[?6.@ZO>Z_:Q>(_#;7UKKK:_?Z9
MI]WI4I7\AGA+Q)J?A7Q!X:\7Z3.UMK'AG7= \4:7-&64P:MH>I6NL6,Z$'Y6
MBN[2*0'.=P+'DDDKWN*O"S#YOCZ6.R/ZIEE.K0OBZ$*:IT9XA5'RU:-#GY**
ME2OSQIQA!RM+D35WX^0<>ULOP<\+FOM\PJ4ZMJ-:4G*<:3C=PG42YJC4]G)R
M:2MS6T/]07]J_P#X+#^(O"?Q$U#]FK]BO]E[XV_M%?M*G4+K0"OB?X3_ !#\
M#?#OPQJ=NZQ3ZA>VFO:/X;\5>)M-L2?MEQJ2MX3\$'2I8=7'C\6$L$DW'?!3
M_@D/X_\ C_XQTC]I3_@K1\4=2_:1^++HE]X=^ 6E:NVF_ OX4P7""YCT&6R\
M/?V98^(I]/G:-+O3?#T>D^$;RXMY_P#A()?B(+A]6N/WX$4:[HS.Y(*NRET+
M(KDJG!7<(R4D5"<Y828.X';8" JOS'@#H1CIUY!ZY_0=Z_F[V=YWJ3=2-[PA
MR\D8+3>*;55IZ.4MGI;:_P#6U'Q&>19/3RO@/(,/P=CL1A'A\\XLAF&(SCB_
M-?:TW2Q>%P6=8K#X9<-95BTY>TP.083"8FK0J*CB,XJ4XSIU?SK_ ."A?Q9T
MK]BO_@GQ\>?'7PRTK0? =SX.^'8\%?"_2?#-E8>&=-\-^)O'6I:=X \*77A[
M2])MK>PMIO#VI>(;?7[6TL[>-7;2=BA$W%/SO_X('_\ !/?0?@C\"M(_:Z^)
M.A1ZC\=?CWH[:KX1O-6C^TW?P^^#FJ?O-%@TM;C<UKKWQ&@5O%GB+64;[7<^
M'M1\/:$IMC:ZRNI_07_!>7PAJ?CK]@F[\*Z>["+6OV@_V<=$U5RYC5=.\4_%
M#1_"D1E9"G[E=6UW32=Q&UPD@.Y :_87P[H.E>&-#T?PUHEM'8Z-H.DZ;H.E
MV4,:1066F:38P:=8VD,:*JI%;VL$4<:* BJH"JH&*4H7Q'.TY1I4H^SCII*I
M)MN*VB^6,8\RM976BN>O'B*MD7@K'*<OKU*>/\1.-\\J<3XR%6?UG$Y+PE@<
MDP^!RFO6=1UYT<?F.>5\RQ2G5E'$0I1IUHUDYN?R1^UW^VI\-/V2=#TJ+5K2
MZ\9_$KQ7;SR^"OAEH-U;VVJZI;VTGER:WKM_-#<P^&?"UO<$VK:O<V]S<WMS
MY]KHVG:G/97PL_Q[US_@H+^WUX_O1JWAG4? OPPTK$AM]"\-^ M.U\^1((WA
M.H:KXW7Q!=7%Q&IQY]G!ID,Q+L;!$"LGS%XC^)%G\:/C'\<_VF?B=J<UOX7T
MZY\6>(9+J6"6Z3PQ\*_A[::G=Z;965FC2R&/2O"^DR7;V=KN-]J4]_=QA;B^
M?'\6W[37_!;G]N'XW?$;6=<^$7Q<\7?LV?"6WU"XC\ ?#3X57]KX>NM.\/03
MO_95SXU\56=J==\7^++NR6WEUZ\N=070EOVGAT'1-(T[%N_['/"<.<$X/ T\
MSRRAG6=XRC#$8CZS2CB*.'C.*G*CAJ,ZU+#PI0C4A3G7J4JU6I.,JD$J<H1I
M_P U4ZF8Y]5K5:&*K8' 4YRA2A0DZ,JD>=QA5K5:3A7=5J#;A":PRNHR@[(_
MT,?A?_P5+_:!^&VJ:?I_[2/@G1/B%X-\R.#5?%W@C1SX8\=Z9%)(#)JC:,+H
M^%O$,=M&&+Z59V?AFYDC4M#>37/EVLW[K> /'W@WXJ>"O#_Q \!>(=/\4^$?
M%>G+J6B:WIS&2WN[8R/!(DL;(D]I>V-U%<6&IZ=>1V]]I6HVUSIVH06U[:W$
M4?\ GK_\$8_^"G?A#]K7X<>)/V2OVN_'7Q(^('[;>K>*/%.N? 3QA=^%/"EE
MX-\0_"7P?X&TSQ?XCT3QGXITB73]1U?QU86>D_$34K:>^T![F;3M+\/^9K=S
M*U]'7]/_ /P29\?:MX5^)WQE_9WN)Y9_#&H:0GQ9\+VLCF2+1M8L=3T_PWXM
MCM\DF./7+:^\.74D*,L,5WI4UPD0FU&ZDD\G.,NR//,AQG$>18-Y3B<LFIYA
M@:;E'#UL+S455JT:4JM6-.M1GB:+INDX4JM-U8RIJ=*G)]F$Q&.R_'8?+L;B
M)8S#XK3#XBHH>VI5E&I[.//%*<H5(PJ)NI)U(247*34ER_M#<S^"/B WC?X=
M^(-,TC7X=/M[73/&'@_Q+8:?JEAJ.@^);*2XTNXO]&OA>6FI>'=>B@O[6VDN
M[=[:ZO=*U?3Y(Q=:7=Q1_P TG[>G_!"?4/!VNV_[47_!,_4-2^''Q0\#:S:>
M-[;X)6.L/:VZ:WHTRZA#K7P3\0:C<23^&]<MKF)KD> ==O+GPUJD2SZ?H-WH
M<:6V@:I^TO[1WC9?@M^U-^QCX[,KV^C_ !P\6^,OV2_&L$1F:/4KCQ;X3U3X
MH_"74KFW1UAENO#'C'X=ZWH^FW+J'L--^)'BD1Y2\=1]YM C#!+8YXR,<[NQ
M!Z;N!TX7.<"O@,9@'##X*O5CS4L?AJE?#SO[\9T,77P6)AS67*Z=:E%JS=XS
M@VHN5C]7X!\2N)^ <XQ>*X:Q\J5.-2.%SK)<9'ZUD>=X/$8:,YX3-,LJRE0Q
M5'$86M6IQQ$84<7AYSE.AB7*FH/\W_\ @F;^W;;_ +;GP(DU#Q;IT_@S]HKX
M0Z@GPX_:.^&6HZ=+H6K>%OB%I4<]M+K8\/W\,&I:1HGBYK&[O[.PO8%ET'5[
M?7/"5P\]WX=N;F?](XVW(&R3G/48/4XR !CCMCZ\U\#_ !C_ &8E\-?'K0_V
MU?V?])BTKXX:+IT7A'XT^$M/6.RTK]IKX+N\4>I^%O$<:!(Q\4O R6MKXJ^#
MWC!E2>ZUS0[;X>^);L>$O$4FH>'?NS2[VWU+3K+4+1I'M;ZVAN[9I89K>4P7
M"":'S;>X2.XMY?+=1)!/''/"^Z*9$D1E'-%24$II<RT4D[N4>CDNDK)7O=WN
M[V9S\5SR'&9I/..&L/++LKS9RQ53(9U'5EPYF=1^VQ^44:TO?Q.5TZM6=;(\
M3.]6>4U</AL8J689=B(5O(_VD#_QC[\=Q_U1;XI''_<CZ[C^M?XR?@8?\5!X
M-X^;^V_#H_\ *QIX Q[Y(&.N>.U?[3/Q0\+S>./AU\0?!5M*L-QXP\"^+/"L
M$SD!8IO$&@:EI,4C$Y "27:L201@'@X(K_%;@@UOPMJ<5O?:?)IGB+POJ)MK
M[2]0C,5QIVO^'KY4O=-OHCG9-8ZE92VMW&23%)%*&/REJ_>O!B2EA.)J,9)5
MO;8":BY*+<)83'4H33;4>5UW&"O*+]K'EBG)1YOY]\3DX5<CJM6IJ6(3GI:\
M:M"<HW[J";L^B/\ ;>7[W_ 1_(5)7X?? [_@X6_X)5?%;X<^#?%OB+]JCPC\
M)?%>M>&=(U#Q1\.OB9HOC#0/$O@WQ!+9P?VUX>U&[_X1Z;P]JTNF:CY]K'J?
MAW5]5TC4H8Q>Z?>3VKK(?9?^'X__  28_P"C[O@3_P"#;7!^G]AG%?CU3AWB
M"E.=.60YQS0G*,K99C&FXRE'FC)8>49PERWC.,G&4;2BVFC]'I9SE,Z5.4<R
MP4HRIPDFL50VE&,DFI58M22:4HN*<6FGJF?JVV-K9Z;3GMQCUK_+:_X.0,?\
M/A_VJ/?3O@;R/;X$?#L8SV(.<CKZ]J_NVUC_ (+M_P#!)#1[*:]N?VZ/@[<1
MQHY,>CP>-?$-X=JEL1Z=H7A:_OYF(!VI'!N8X5>2#7^<+_P53_:T\+?MQ?M_
M?M(?M,^ +35K;X>^/_%6AV'@%-;L_P"SM8N/!W@7P;X<\!:+JNH:<Q:;3[CQ
M!#X;?Q$=.N2UYIJ:JEA=A9[9T3]1\)<GS7!Y_CL7C<KQ^#PT,JJ4?;XS"5L+
M2]K6Q6'DJ<:F(A2BY.G3FY)/2*]YV:1\#XBYE@,1D^&P^'Q>'KUYX^E45.C5
MIU)*G3I5G*<N2<E&*<TES25Y/1.S9]"?M%<?\$3O^"9 '&/VI?V[P?J=0^'.
M[K[D_P!*Y?\ X)A_LK?M>_M@>%OVX_A'^QU\2Y?!WC27]GKPWK7C3X<P3V?A
M^;]H3P#:?$S1QJ?PEB\?S7-K=>#I+Z9H=3CLQ<6F@>.I+-/!/C/4;'PUK%_<
M+[/^V'X#U3P1_P $/?\ @D)=:Q:7-E<^._C%^V]\0+2"ZC,32:1KOC/PY9:%
M?QJPWM::KHVE6.JV4V MS;7T-S'^YECK]%O^#08%_P!L']JU22,?LSZ$<C&0
M1\5/#YXR".J CCC)QVQ^A9AF53+^#N(<RPBP]>>$SS.ZU*->E#$8:56CQ13<
M%5I2YHU(7I5++LXS6L8<ORF$P<,;Q1DV"Q#K4X8G*LMI3=.=2A7A&6358.<)
MQ<7'E>KA)6J1?*URN5_Y6KG0=8^$WQ+;P]\4?AI=)KOPW\:V=E\0/@]\1+/Q
M5X,NYY_#>K6[^(/A[XSL](O?#/C7PW'JD%O/HFKR:1J6@^(K*SO9;O2-5T^^
M%M?Q_P"I?_P1]_X*-?L;?MR?LZ^&O"W[,N@>&_@;XB^#OAC2-%\8?LGVITO3
MM3^$6G6PBM8;KPO9Z?:Z9;^*_AQ>WDA&E^.M*TY([R^N/LWB6VTCQ.UUI=>1
M_P#!8/\ X(?_  7_ ."F?AR\^(WA";1O@[^V%X9T9+/P?\7!IKG0/B#9Z;;-
M_9G@3XTV6G1?;-8T$Y-CHOC.QCN?%?@??#<6T/B+0[.;P?J7^=KJNE?MB_\
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M2U>X2X\/)XFTC5I/V3/VO?@S^V9\)=+^+/P9UBXN+%G&D>+_  =KT<6E^/\
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MQ_\ "[6KU5=EMI)Y+=/$O@W4KF"T;Q5X#U.Z@TK7HH(KBWNM'U^UTKQ!IGZ
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MB^,'AV*TN+BW7Q!IO@_4?&'@J]:V;#RZ=XX\%Q^(/"MY"4*R+LU<2"%DD>)
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>?&4Y0G]>PD$E0KSCS\U*HJ<84I1D]5"+25I.7__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
